TC-99M NANOCOLLOID AND TC-99M MDP 3-PHASE BONE IMAGING IN OSTEOMYELITIS AND SEPTIC ARTHRITIS - A COMPARATIVE-STUDY

被引:15
|
作者
MUDUN, A
UNAL, S
AKTAY, R
AKMEHMET, S
CANTEZ, S
机构
[1] Department of Nuclear Medicine, Faculty of Medicine, Istanbul University
关键词
D O I
10.1097/00003072-199509000-00004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The aim of this study was to compare Tc-99m nanocolloid scintigraphy with Tc-99m MDP bone imaging in the diagnosis of osteomyelitis and septic arthritis. Overall, 31 Tc-99m MDP bone scans and 39 Tc-99m nanocolloid studies were performed in 34 patients (15 female, 19 male; mean age, 14.88 years +/- 19.00 years) who were suspected of osteomyelitis and/or septic arthritis. The final diagnoses were established by needle aspiration, cultures, radiography, clinical course, and, in some patients, with CT, ultrasonography, and biopsy. The sensitivity, specificity, and accuracy were 100%, 75%, and 92%, respectively for both Tc-99m MDP and Tc-99m nanocolloid scans in detecting osteomyelitis. For septic arthritis, Tc-99m MDP bone imaging showed 100%, 85%, and 94%, and Tc-99m nanocolloid scans showed 90%, 59%, and 76%, sensitivity, specificity, and accuracy, respectively. These results show that, although both scans are in good agreement for osteomyelitis, for septic arthritis nanocolloid is not specific enough to recommend it to be a complementary method to MDP bone scans.
引用
收藏
页码:772 / 778
页数:7
相关论文
共 50 条
  • [21] The comparision of Tc-99m MIBI and Tc-99m MDP scintimammography in detection of breast lesions
    Atalay, M
    Uluc, E
    Polat, M
    Gür, S
    Çökmez, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1119 - 1119
  • [22] TC-99M BONE SCANNING AGENTS .3. PREPARATION AND GEL CHROMATOGRAPHY OF TC-99M(SN)MDP COMPLEXES
    KROESBERGEN, J
    GELSEMA, WJ
    DELIGNY, CL
    INTERNATIONAL JOURNAL OF NUCLEAR MEDICINE & BIOLOGY, 1986, 12 (06): : 419 - 424
  • [23] Septic arthritis of the acromioclavicular joint - Tc-99m leukocyte imaging
    Zicat, B
    Rahmme, DM
    Swaraj, K
    Qurashi, S
    Loneragan, R
    Van der Wall, H
    CLINICAL NUCLEAR MEDICINE, 2006, 31 (03) : 145 - 146
  • [24] TC-99M BONE SCANNING AGENTS .6. GEL CHROMATOGRAPHIC ANALYSIS OF THE PLASMA-PROTEIN BINDING OF TC-99M (SN)PYROPHOSPHATE, TC-99M (SN)MDP AND TC-99M (SN)HMDP
    KROESBERGEN, J
    ROOZEN, AMP
    WORTELBOER, MR
    GELSEMA, WJ
    DELIGNY, CL
    NUCLEAR MEDICINE AND BIOLOGY, 1988, 15 (05): : 479 - 487
  • [25] Tc-99m MDP and Tc-99m MIBI in the assessment of spondyloarthritis presenting as bone metastasis before treatment with infliximab
    Hadi, A
    Al-Nahhas, A
    Vivian, G
    Hickling, P
    CLINICAL NUCLEAR MEDICINE, 2002, 27 (04) : 297 - 298
  • [26] Differentiation of malignant and degenerative benign bone disease using Tc-99m MDP and Tc-99m citrate scintigraphy
    Sharma, R
    Mondal, A
    Bhatnagar, A
    Chakravarty, KL
    Mishra, P
    Chopra, MK
    Rawat, HS
    Kashyap, R
    CLINICAL NUCLEAR MEDICINE, 1998, 23 (11) : 758 - 763
  • [27] TC-99M MDP UPTAKE IN HEPATOBLASTOMA
    ELGAZZAR, AH
    JAHAN, S
    MOTAWEI, S
    ABDELDAYEM, HM
    CLINICAL NUCLEAR MEDICINE, 1989, 14 (02) : 143 - 143
  • [28] RHABDOMYOSARCOMA CONCENTRATING TC-99M MDP
    CASARA, D
    BONAZZA, A
    JOURNAL OF NUCLEAR MEDICINE, 1983, 24 (11) : 1082 - 1083
  • [29] UPTAKE OF TC-99M MDP BY HEPATOBLASTOMA
    CORY, DA
    SIDDIQUI, AR
    COHEN, MD
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1987, 12 (11): : 546 - 547
  • [30] TC-99M MDP ACCUMULATION IN LYMPHOMA
    MALPANI, A
    TAKAMIA, Y
    BEKERMAN, C
    BRANDT, T
    PINSKY, S
    BLEND, M
    CLINICAL NUCLEAR MEDICINE, 1990, 15 (10) : 738 - 739